empe Pretomanid Resistance Is a Question of When, Not If, and Diagnostics Have to Be Ready Before It Arrives Pretomanid Resistance Is a Question of When, Not If, and Diagnostics Have to Be Ready… Read More
empe EMPE Diagnostics to Unveil CircuLOK Product Range at NATCON 2026, Expanding Access to TB Drug-Resistance Diagnostics EMPE Diagnostics to Unveil CircuLOK Product Range at NATCON 2026, Expanding Access to TB Drug-Resistance… Read More
empe Beyond Speed: Why Expanded Drug Resistance Testing Is the Next Frontier in Tuberculosis Diagnostics Beyond Speed: Why Expanded Drug Resistance Testing Is the Next Frontier in Tuberculosis Diagnostics A… Read More
empe Bedaquiline Resistance: Why a Tiered Diagnostic Strategy Is the Way Forward Bedaquiline Resistance: Why a Tiered Diagnostic Strategy Is the Way Forward Bedaquiline has revolutionized the… Read More
empe EMPE Diagnostics Partners with Interprise to Expand Access to TB Drug Resistance Diagnostics Across Brazil EMPE Diagnostics Partners with Interprise to Expand Access to TB Drug Resistance Diagnostics Across Brazil… Read More
empe Lessons from Ukraine: Bringing Next-Generation Molecular TB Diagnostics to the Frontlines Lessons from Ukraine: Bringing Next-Generation Molecular TB Diagnostics to the Frontlines How a health system… Read More
empe Tuberculosis Kills More People Than Any Other Infection. Here’s How We’re Building the Company to Change That. Tuberculosis Kills More People Than Any Other Infection. Here’s How We’re Building the Company to… Read More